CDOWST

What this means for you

This application is over — abandoned 23 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

90254987

Mark type

Stylized text

Filed

14 Oct 2020

Published for opposition

27 Apr 2021

Abandoned

23 Jan 2023

Attorney of record

Monica Riva Talley

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community

Owner

• Seres Therapeutics, Inc., Cambridge, MA, US
• Seres Therapeutics, Inc., Cambridge, MA, US

Prosecution history

• 23 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 23 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
• 18 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 16 Jun 2022 — SOU EXTENSION 2 GRANTED
• 16 Jun 2022 — SOU EXTENSION 2 FILED
• 16 Jun 2022 — SOU TEAS EXTENSION RECEIVED
• 10 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 08 Dec 2021 — SOU EXTENSION 1 GRANTED
• 08 Dec 2021 — SOU EXTENSION 1 FILED
• 08 Dec 2021 — SOU TEAS EXTENSION RECEIVED
• 22 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 27 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 27 Apr 2021 — PUBLISHED FOR OPPOSITION
• 07 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 19 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER